<DOC>
	<DOCNO>NCT01559753</DOCNO>
	<brief_summary>The duration treatment community acquire pulmonary infection vary 5 14 day accord author ( 22 ) , even 3 day new drug long half-life ( 2 ) . For nosocomial pulmonary infection , treatment duration standardize ( 5 ) . It simply mention concept `` usual '' treatment least 15 day . However , recent study use 10 day treatment without significant decrease rate healing compare usual treatment . It essential clarify optimal duration antibiotic treatment . Indeed , excessive extension treatment may increase occurrence adverse effect ( renal toxicity , hepatic ... ) , induce resistance bacteria antibiotic ( selection pressure ) , colonization patient Multiresistant bacteria increase cost treatment</brief_summary>
	<brief_title>Early-onset Ventilator-associated Pneumonia Adults : Comparison 8 Versus 15 Days Antibiotic Treatment</brief_title>
	<detailed_description>This prospective , randomize , open , multi-center study . 3.1 Primary Objective Show antibiotic therapy 8 15 day equivalent term clinical cure rate treatment early onset nosocomial pulmonary infection patient mechanical ventilation . 3.2 Secondary Objective - Study nosocomial infection : assess influence duration antibiotic treatment rate fatal pulmonary extra-pulmonary infection ( definition nosocomial infection : annex XIII ) . â€¢ Study bacterial Ecology : research change flora gut treatment analysis pathological sample ( antibiotic resistance phenotype +/-genotypes ) . - Economic Survey : analyze cost related treatment nosocomial pneumonia complication two study group .</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia , Ventilator-Associated</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Tobramycin</mesh_term>
	<mesh_term>Ceftriaxone</mesh_term>
	<mesh_term>Clavulanic Acids</mesh_term>
	<mesh_term>Clavulanic Acid</mesh_term>
	<mesh_term>beta-Lactams</mesh_term>
	<mesh_term>Cefotaxime</mesh_term>
	<mesh_term>Cefoxitin</mesh_term>
	<mesh_term>Lactams</mesh_term>
	<mesh_term>Amoxicillin-Potassium Clavulanate Combination</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<mesh_term>Netilmicin</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<criteria>Early onset nosocomial pneumonia patient mechanical ventilation since least 24 h Patients age 18 year The patient must able receive either one two arm treatment define study Information patient family inform consent obtain first three day Bacteria sensitive specify antibiotic regimen Patients match criterion inclusion 18 year age , pregnant Patients Another infectious outbreak document day BAL . Patients acquire immunosuppression ( blood disease , HIV , ... ) , induce ( immunosuppressive drug , cancer , radiation therapy ) congenital . Steroids period exceed 15 day . Leukopenia ( 1000 GB/mm ( neutropenia ( 500 PN/mm ) Purulent pleural effusion , pulmonary abscess Cystic fibrosis Antibiotic treatment accord follow term : 1 . Ongoing curative antibiotic therapy 2 . Antibiotics within 3 day diagnosis VAP , except surgical antibiotic prophylaxis ( define accord consensus conference `` antibiotic prophylaxis surgical environment adult '' December 11 , 1992 ) ( 27 ) 3 . Use antibiotic authorize study ( see list ) Allergy antibiotic use study Inclusion another study assess antibiotic treatment , either treatment prevention nosocomial pulmonary disease Refusal participate Lack informed consent patient family</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Antibiotic</keyword>
	<keyword>treatment</keyword>
	<keyword>ventilator associate pneumonia</keyword>
	<keyword>duration</keyword>
</DOC>